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Abstract objective To measure linkage to care and antiretroviral therapy (ART) initiation among newly
diagnosed individuals with HIV in a rural Tanzanian community.
methods We included all new HIV diagnoses of adults made between 2014 and 2017 during
community- or facility-based HIV testing and counselling (HTC) in a rural ward in northwest
Tanzania. Community-based HTC included population-level HIV serological testing (sero-survey),
and facility-based HTC included a stationary, voluntary HTC clinic (VCT) and an antenatal clinic
(ANC) offering provider-initiated HTC (ANC-PITC). Cox regression models were used to compare
linkage to care rates by testing modality and identify associated factors. Among those in care, we
compared initial CD4 cell counts and ART initiation rates by testing modality.
results A total of 411 adults were newly diagnosed, of whom 10% (27/265 sero-survey), 18% (3/
14 facility-based ANC-PITC) and 53% (68/129 facility-based VCT) linked to care within 90 days.
Individuals diagnosed using facility-based VCT were seven times (95% CI: 4.5–11.0) more likely to
link to care than those diagnosed in the sero-survey. We found no difference in linkage rates between
those diagnosed using facility-based ANC-PITC and sero-survey (P = 0.26). Among individuals in
care, 63% of those in the sero-survey had an initial CD4 count >350 cells/mm3 vs. 29% of those
using facility-based VCT (P = 0.02). The proportion who initiated ART within 1 year of linkage to
care was similar for both groups (94% sero-survey vs. 85% facility-based VCT; P = 0.16).
conclusions Community-based sero-surveys are important for earlier diagnosis of HIV-positive
individuals; however, interventions are essential to facilitate linkage to care.
keywords HIV, HIV testing, linkage to care, population surveillance, longitudinal studies,
sub-Saharan Africa
Introduction
HIV testing and counselling (HTC) is the first critical step
for subsequent linkage to care and initiating antiretroviral
therapy (ART). However, linkage to care following a
positive HIV diagnosis remains low in sub-Saharan
Africa. A 2015 meta-analysis found that linkage to care
within 12 months of diagnosis was only 61% (95% con-
fidence interval [CI] 48–72%) among individuals diag-
nosed using facility-based, voluntary HTC (VCT) and
55% (95% CI 39–71%) among those diagnosed using
facility-based, provider-initiated HTC (PITC) [1]. Further,
linkage to care may vary by throughout the region [2],
emphasising the need for locally appropriate interventions
to improve linkage to care and subsequent access to
ART.
In order to expand access to HIV testing and increase
linkage to care and treatment services, WHO recom-
mended community-based HTC with facilitated linkage
to care services (for example, a lay-counsellor follow up
to encourage a clinic visit) in addition to traditional,
facility-based HTC [3]. Community-based HTC includes
services that are delivered using mobile and home-based
approaches thus removing structural, logistical and social
barriers to HTC [4]. While community-based HTC can
increase the number of individuals who knows their HIV
status [5–8], it may also increase the proportion of people
living with HIV who knows their status but does not link
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to HIV care services. A 2015 systematic review found
that, only 30% of individuals diagnosed with HIV using
mobile and home-based HTC without facilitated linkage
were linked to care within 12 months [1]. Major limita-
tions of previous systematic reviews [1, 9] on linkage to
care following community- and facility-based HTC are
that linkage outcomes were reported without differentia-
tion between newly and previously diagnosed HIV-posi-
tive individuals and the use of both directly observed and
self-reported linkage to care. Individuals who previously
tested HIV-positive and have not yet linked to care are
likely to differ from newly identified patients with regard
to barriers that may prevent service uptake [10, 11].
Population-level HIV serological surveys (sero-surveys)
are a unique form of community-based HTC that include
repeated rounds of HIV testing, in which temporary clin-
ics are constructed in numerous locations throughout a
community to test all eligible individuals in the popula-
tion and refer those who test HIV-positive to register for
care at a stationary HIV care and treatment centre (CTC)
[12]. While diagnoses during a sero-survey are made rela-
tively closer to participants’ homes, the stationary CTC
may be further away, and transportation costs could
become a barrier to obtaining care [13]. Some sero-sur-
vey systems have offered transportation allowances and
volunteer escorts to mitigate such barriers and facilitate
linkage to care [14]. Although sero-survey provisions can
differ across sites, they are distinct from mobile HTC
approaches in four key ways. First, sero-surveys are often
conducted within a surveillance system whereby all eligi-
ble residents receive an invitation to participate. Second,
in addition to HTC, participants in a sero-survey are
interviewed on a range of topics including family plan-
ning, sexual behaviour, HIV testing history and use of
ART. Third, participants in a sero-survey are routinely
given a choice whether they want to receive their HIV
test results, although sites can differ between using an
opt-in or opt-out approach. Fourth, repeated rounds of
sero-surveys, with a unique identifier linking all previous
test results, allow for the identification of individuals
who are newly diagnosed with HIV. The latter two char-
acteristics also serve to distinguish sero-surveys from
sero-prevalence surveys as they are conducted in Demo-
graphic and Health Surveys, which do not disclose results
to participants and cannot readily link participation
records across multiple rounds. Whether newly diagnosed
individuals with HIV during a sero-survey link to care at
different rates than those diagnosed in facility-based VCT
or PITC remains unknown.
In 2015, we introduced a system to link individuals’
sero-survey records with directly observed HIV testing
and care records in a community in northwest Tanzania
[15–17]. In this paper, we use the linked data to compare
the time from a new HIV-positive diagnosis to successful
linkage to care by testing modality (community-based
HTC provided during sero-surveys vs. facility-based VCT
or PITC provided at stationary clinics). We further
explored demographic and spatial characteristics associ-
ated with linkage to care. Finally, among those in care,
we compared initial CD4 cell count and ART initiation
rates by testing modality.
Methods
Data sources
The Kisesa observational HIV cohort study was estab-
lished in 1994 and is located in a rural ward in the Magu
district of Mwanza region in northwest Tanzania [18].
Kisesa ward consists of seven villages with a main road
running through large portions of four of the seven vil-
lages (Figure 1). The study includes annual or bi-annual
rounds of health and demographic surveillance surveys
(HDSS) that cover the entire population of approximately
35 000 residents, and multiple rounds of sero-surveys, in
which adults aged 15 years or older living in the Kisesa
HDSS are invited to attend a temporary village-based
clinic for a personal interview and provide blood samples
for anonymous HIV testing. The Kisesa sero-survey sys-
tem uses an opt-in approach for offering individuals their
HIV test results.
A government-run health centre is located on the main
road within the Kisesa HDSS area, which includes a sta-
tionary VCT clinic, an antenatal clinic (ANC) offering
PITC (ANC-PITC) and a CTC. For the stationary VCT
and ANC facilities, we developed electronic databases
and digitised the paper-based logbooks using a double-
entry system where two different fieldworkers indepen-
dently captured each book, and any discrepancy between
fields were reconciled in a third cleaning stage. The CTC
databases have been fully digitised, and data clerks regu-
larly updated and ran data checks on these data.
Data linkage
Participants’ records from all sero-survey rounds are
cross-referenced with their HDSS identifiers as part of the
identification process during the survey interview.
Records from the three clinics were linked to the HDSS
database using point-of-contact interactive record linkage
(PIRL) [16, 17]. Briefly, as individuals arrived any of the
three stationary clinics and consented to be in the study,
fieldworkers entered the personal and residence details
into specialised computer software [15], which used a
© 2018 The Authors. Tropical Medicine & International Health published by John Wiley & Sons Ltd. 1385
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probabilistic linkage algorithm to search the HDSS data-
base. While searching through potential matches, the
fieldworker could view the full list of household members
associated with each HDSS record as an additional step
to adjudicate true matches. The fieldworker then inter-
acted with the patient to identify which HDSS record(s),
if any, was a true match. Among those who reported resi-
dence history in the surveillance area, PIRL matched
84% to at least one HDSS record, and this did not differ
across the three clinics [17].
Analytic sample
This analysis included all sero-survey participants, and
HTC and ANC users who received a new HIV-positive
diagnosis between December 2014 and October 2017.
Date ranges varied by the source (Table 1). Individuals
younger than 15 years of age who received their HIV
diagnosis in a clinic were excluded (to be consistent with
the 15-year age limit in the sero-survey). Individuals were
also excluded if their records were not linked with PIRL,
had already received a positive HIV diagnostic test, or
reported residence outside the HDSS area or were not
seen in the 2016/17 HDSS survey (non-residents). We
extracted demographic characteristics including sex, age,
rurality of sub-village (rural, peri-urban, or urban),
whether the sub-village of residence had a road and geo-
desic distance between an individual’s household and the
CTC.
Outcomes
The CTC data included all registrations and visits up
to November 2017 at Kisesa health centre. The
Kisesa health centre
Kisesa clinic
B6 to Mwanza
Kanyama clinic
Igekemaja clinic
Kitumba clinic
Welamasonga clinic
Ihayabuyaga clinic
Isangijo clinic
N
B6 to Kenya
Legend
Paths
Village boundaries
Sero-survey clinic0 2500 5000 10 000 Meters
Abbreviations: sero-survey – HIV serological surveillance survey; B6 – main road, paved
Figure 1 Location of sero-survey clinics and Kisesa health centre in Kisesa, Tanzania. Sero-survey – HIV serological surveillance survey;
B6 – main road, paved. Notes: Kisesa health centre includes the HIV care and treatment centre (CTC), HIV testing and counselling clinic
(HTC), and antenatal clinic (ANC); map courtesy of Jocelyn Poppinchalk. [Colour figure can be viewed at wileyonlinelibrary.com].
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primary outcome was successful linkage to care, defined
as the first visit to the CTC including consultation with
a clinician within 90 days of diagnosis. Limiting the
time frame to 90 days provided a fairer comparison
between those who were diagnosed in a health facility
and those who were diagnosed in the sero-survey, given
the longer time period between the end of the sero-sur-
vey and available CTC registrations. Among those who
linked to care, secondary outcomes were initial CD4
cell count (within one year after linking to care) and
ART initiation within 90, 180 or 365 days of linkage
to care.
There were other health centres in wards near the Kis-
esa HDSS surveillance area (all about 5–10 km away
from Kisesa health centre via a main road) that offered
CTC services during the study period. Of note, this anal-
ysis only captured CTC registrations that occurred at Kis-
esa health centre.
Statistical analyses
We used chi-square tests to compare demographic and
spatial characteristics between individuals who did and
did not link to care. A Cox proportional hazards
regression model was used to compare linkage to care
rates by testing modality and identify associated fac-
tors. Individuals were censored at first CTC visit, death
or 90 days after positive HIV diagnosis. We considered
all demographic and spatial characteristics and their
interaction terms with testing modality for inclusion in
an adjusted model. Interaction terms were eliminated
from the model using likelihood ratio tests for signifi-
cance. Remaining terms were assessed for multi-
collinearity and dropped in a stepwise fashion until
there was no further evidence of multicollinearity in
the model.
Among those who linked to care, we compared ini-
tial CD4 cell counts and the cumulative incidence of
ART initiation within 90, 180 and 365 days after hav-
ing successfully linked to care by testing modality using
chi-square or Fisher’s Exact tests. Given the proximity
between the CTC and the stationary VCT and ANC
clinics (<25 m), we performed sensitivity analysis by
excluding individuals who linked to care on the same
day as receiving their HIV diagnosis in either of the
stationary clinics as all remaining individuals would be
required to use transportation to visit the CTC on a
subsequent day. This exclusion could be seen as provid-
ing a fairer comparison to individuals who obtained
community-based HTC in that those who were diag-
nosed in a stationary clinic had to return to Kisesa
heath centre on a subsequent day. We also performed
sensitivity analysis on ART initiation rates by excluding
individuals who had a CD4 cell count >500 cells/mm3
at CTC registration to mirror treatment guidelines dur-
ing part of the study period. Statistical analyses were
performed using SAS version 9.4 (SAS Institute Inc.,
Cary, NC, USA).
Ethics
Ethical approvals were obtained from the Tanzanian
National Institute for Medical Research and Lake Zone
Institutional Review Board (reference no. NIMR/HQ/
R.8c/Vol.II/436 and MR/53/100/450), and the London
School of Hygiene and Tropical Medicine (Project ID
#8852). Informed written consent was obtained from all
participants.
Table 1 HIV testing date range and
exclusion criteria, by testing modality Facility-based
Community-based
sero-surveyANC-PITC VCT
Minimum HIV+ test date 30/12/2014 15/06/2015 09/09/2015
Maximum HIV+ test date 27/12/2016 03/10/2017 26/02/2016
Number of HIV+ diagnoses 24 159 476
Exclusion criteria
Previous diagnostic HIV+ test 6 (25.0) 12 (7.6) 204 (42.8)
Non-resident 1 (4.2) 18 (11.3) 13 (2.7)*
Total in analytic sample 17 129 265
HIV, human immunodeficiency virus; ANC, antenatal clinic; PITC, provider-initiated
HIV testing and counselling; VCT, voluntary HIV testing and counselling; sero-survey,
population-based HIV serological surveillance; HIV+, HIV-positive. PITC offered
through a stationary, antenatal clinic; VCT offered through a stationary, HIV testing
and counselling clinic.
*These individuals were residents during the 2015/16 sero-survey but subsequently
moved out of the area.
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Results
Sample characteristics
Between 2014 and 2017, 659 adults received a positive
HIV diagnostic test (476 community-based sero-surveys,
159 facility-based VCT, 24 facility-based ANC-PITC).
After excluding individuals who were previously diag-
nosed (222/659, 33.7%) and non-residents (32/659,
4.9%), 411 individuals remained in the analytic sample
(265 community-based sero-survey, 129 facility-based
VCT, 17 facility-based ANC-PITC) (Table 1).
Among the 411 individuals who were newly diagnosed
with HIV, 98 (23.8%) linked to care within 90 days of
their diagnosis. Of note, only eight individuals in this
sample linked to care between 91 and 365 days of diag-
nosis. By testing modality, linkage to care was higher
among those diagnosed using facility-based VCT (68/129,
52.7%) than those diagnosed using facility-based ANC-
PITC (3/17, 17.7%) or community-based sero-survey (27/
265, 10.2%) (P < 0.0001) (Table 2). Individuals who
resided in Welamasonga (8.9%) or Ihayabuyaga (12.8%)
were less likely to link to care than those who resided in
Kanyama (33.3%) or Kitumba (35.9%) (P = 0.009).
There were no significant bivariate associations between
linkage to care and sex, age, rurality of sub-village,
whether the sub-village had a paved road, and distance
between household and CTC (all P > 0.09). However,
after excluding individuals who linked to care on the
same day as receiving their HIV diagnosis, there was a
statistically significant association between linkage to care
and distance between household and CTC (16.0% for
<1 km, 21.9% for 1–1.9 km, and 20.7% for 2–4.9 km;
P = 0.03).
Associations with linkage to care
Median time from diagnoses to linkage to care was
20 days (interquartile range [IQR] 4–47 days) among
those diagnosed in the community-based sero-survey and
1 day (IQR 1–14 days) among those diagnosed using
facility-based VCT. All three individuals diagnosed using
facility-based ANC-PITC who linked to care did so on
the same day as diagnosis. In an unadjusted model, indi-
viduals diagnosed using facility-based VCT were seven
times more likely to link to care than those diagnosed in
the community-based sero-survey (hazard ratio [HR]
7.01, 95% CI 4.47–10.97) (Table 3). There was no sta-
tistical evidence that individuals diagnosed using facility-
based ANC-PITC linked to care at higher rates than
those diagnosed in the community-based sero-survey (HR
1.90, 95% CI 0.58–6.27).
The final adjusted model included sex, age, rurality of
sub-village (urban, peri-urban, rural), whether the sub-vil-
lage had access to a paved road and distance between
household and CTC. The associations between linkage to
care and testing modality remained after adjustment (HR
6.95, 95% CI 4.39–11.00 facility-based VCT; HR 2.00,
95% CI 0.59–6.75 facility-based ANC-PITC) (Figure 2).
No other significant associations were found after
adjustment.
Table 2 Characteristics of individuals who received their first
positive HIV diagnosis between 2015 and 2017 in Kisesa, Tanza-
nia, by whether they subsequent linked to care
Characteristic
Linked to
care
Did not link
to care
P-value(n = 98) (n = 313)
Testing modality
Facility-based VCT 68 (52.7) 61 (47.3) <0.0001
Facility-based ANC-
PITC
3 (17.7) 14 (82.3)
Community-based
sero-survey
27 (10.2) 238 (89.8)
Sex
Male 40 (28.8) 99 (71.2) 0.0934
Female 58 (21.3) 214 (78.7)
Age, years
15–29 31 (25.8) 89 (74.2) 0.9237
30–39 35 (23.8) 112 (76.2)
40–49 18 (22.5) 62 (77.5)
50+ 14 (21.9) 50 (78.1)
Village
Igekemaja 12 (26.1) 34 (73.9) 0.0094
Ihayabuyaga 5 (12.8) 34 (87.2)
Isangijo 8 (19.5) 33 (80.5)
Kanyama 20 (33.3) 40 (66.7)
Kisesa 26 (22.4) 90 (77.6)
Kitumba 23 (35.9) 41 (64.1)
Welamasonga 4 (8.9) 41 (91.1)
Rurality of sub-village
Urban 24 (22.0) 85 (78.0) 0.1496
Peri-urban 30 (31.3) 162 (78.6)
Rural 44 (21.4) 66 (68.8)
Sub-village has paved road
Yes 44 (25.7) 127 (74.3) 0.4487
No 54 (22.5) 186 (77.5)
Distance from household to CTC, km
<1 19 (23.2) 63 (76.8) 0.1214
1–1.9 32 (29.9) 75 (70.1)
2–4.9 24 (27.0) 65 (73.0)
5–11 23 (17.3) 110 (82.7)
VCT, voluntary HIV testing and counselling; ANC, antenatal
clinic; PITC, provider-initiated HIV testing and counselling; sero-
survey – population-based HIV serological surveillance; CTC,
HIV care and treatment centre. All statistics are given in n (%);
differences assessed using chi-square tests.
1388 © 2018 The Authors. Tropical Medicine & International Health published by John Wiley & Sons Ltd.
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Initial CD4 count and ART initiation
Among individuals who linked to care, the proportion of
individuals whose initial CD4 cell count was >500 cells/
mm3 was higher among those diagnosed in the commu-
nity-based sero-survey (42%) than facility-based VCT
(16%) (P = 0.05). None of the three individuals diag-
nosed using facility-based ANC-PITC had a CD4 labora-
tory result on record.
Among the 68 individuals diagnosed using facility-
based VCT and linked to care, 55 of 68 (80.9%) initiated
ART within 90 days after linking to care, 59/68 (86.8%)
initiated ART within 180 days after linking to care, and
64 of 68 (94.1%) initiated ART within 365 days linking
to care. Among the 27 individuals diagnosed in the com-
munity-based sero-survey and linked to care, 17 of 27
(63.0%) initiated ART within 90 days after linking to
care, 21 of 27 (77.8%) initiated ART within 180 days
after linking to care and 23 of 27 (85.2%) initiated ART
within 365 days after linking to care. All three individu-
als who were diagnosed using facility-based ANC-PITC
and linked to care initiated ART on their first visit to the
CTC. At each time window, there was no statistically sig-
nificant difference by testing modality of the proportion
of individuals who, having linked to care, initiated ART
(all P > 0.11). The proportion of individuals initiating
ART increased further, yet conclusions remained the
same, when restricting to those whose initial CD4 cell
Table 3 Associations with linkage to
care among individuals receiving their
first HIV+ diagnosis in a population-
based HIV serological survey or health
facility in Kisesa, Tanzania between 2014
and 2017, n = 411
Covariate cHR (95% CI) aHR (95% CI)
Testing modality
Facility-based VCT 7.01 (4.47–10.97)*** 6.95 (4.39–11.00)***
Facility-based ANC-PITC 1.90 (0.58–6.27) 2.00 (0.59–6.75)
Community-based sero-survey 1 1
Sex
Male 1.40 (0.93–2.09) 1.44 (0.93–2.23)*
Female 1 1
Age, years
15–29 1.19 (0.63–2.24) 0.97 (0.50–1.86)
30–39 1.08 (0.58–2.01) 1.12 (0.59–2.11)
40–49 1.01 (0.50–2.02) 1.10 (0.54–2.25)
50+ 1 1
Village
Igekemaja 3.15 (1.02–9.78)*
Ihayabuyaga 1.44 (0.39–5.35)
Isangijo 2.21 (0.67–7.33)
Kanyama 4.26 (1.46–12.47)** –
Kisesa 2.59 (0.90–7.41)
Kitumba 4.74 (1.64–13.70)**
Welamasonga 1
Rurality of sub-village
Urban 1.01 (0.61–1.66) 0.46 (0.16–1.33)
Peri-urban 1.57 (0.99–2.50) 0.91 (0.42–1.95)
Rural 1 1
Sub-village has paved road
Yes 1.12 (0.75–1.67) 1.10 (0.59–2.07)
No 1 1
Distance from household to CTC, km
<1 1.36 (0.74–2.49) 2.22 (0.76–6.45)
1–1.9 1.85 (1.08–3.16)* 1.86 (0.80–4.34)
2–4.9 1.62 (0.91–2.86) 1.40 (0.76–2.59)
5–11 1 1
HIV, human immunodeficiency virus; HIV+, HIV-positive; cHR, crude unadjusted haz-
ard ratio; aHR, adjusted hazard ratio; CI, confidence interval; VCT, voluntary HIV test-
ing and counselling; ANC, antenatal clinic; PITC, provider-initiated HIV testing and
counselling; sero-survey, population-based HIV serological surveillance; CTC, HIV care
and treatment centre; km, kilometres.
*P < 0.05; **P < 0.01; ***P < 0.0001.
© 2018 The Authors. Tropical Medicine & International Health published by John Wiley & Sons Ltd. 1389
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count was <500 cells/mm3, which was the national
guideline for when to initiate treatment for part of the
study period.
Sensitivity analysis
Of the 71 individuals diagnosed using facility-based HTC
(68 VCT and 3 ANC-PITC), 38 (54%) linked to care on
the same day they received their HIV diagnosis (the
ANC, VCT and CTC are located within the same health
centre). After excluding these individuals from the
adjusted model (which included all three from facility-
based ANC-PITC), the association between testing
modality and linkage to care remained, although attenu-
ated (HR 3.89, 95% CI 2.30–6.58 facility-based VCT vs.
community-based sero-survey). In this restricted model,
there was a clear stepped increase in the likelihood of
linkage to care by proximity between household and the
CTC. Compared to individuals whose households were
≥5 km away from the CTC, those who lived closer to the
CTC were significantly more likely to link to care (HR
4.67, 95% CI 1.16–18.76 for <1 km; HR 4.69, 95% CI
1.51–14.56 for 1–1.9 km; HR 2.66, 95% CI 1.17–6.06
for 2–4.9 km).
Discussion
Linkage to care within 90 days was low (24%) among
newly diagnosed adults with HIV between 2014 and
2017 in this rural Tanzanian population. However, indi-
viduals who received their first HIV diagnosis using facil-
ity-based VCT had seven-fold greater linkage to care
than individuals diagnosed using community-based sero-
surveys. Among individuals who linked to HIV care
services, individuals diagnosed in the community-based
sero-survey had proportionately higher initial CD4 cell
counts >500 cells/mm3 than those diagnosed using facil-
ity-based VCT. However, ART initiation rates among
those who linked to care were similar irrespective to HIV
testing modality. While sero-surveys are important for
expanding testing coverage and identifying more recent
infections, our findings highlight the need for additional
interventions to help individuals who are diagnosed with
HIV in a community-based sero-survey round link to care
and treatment.
The low level of linkage to care in our sample is
concerning, particularly among those diagnosed during
the sero-survey, but is comparable to those documented
in South Africa [19] and Zambia [20]. Our finding of
higher uptake of HIV care services among individuals
diagnosed using facility-based VCT than those diag-
nosed using community-based HTC is corroborated by
a 2015 meta-analysis of studies reporting rates of link-
age to care throughout sub-Saharan Africa. Pooling
data from 31 studies, community-based HTC achieved
approximately 30% linkage, facility-based PITC (overall
and not restricted to ANC-PITC) achieved 55% linkage
and facility-based VCT achieved 61% linkage [1], vs.
our findings of 10%, 18% and 53% respectively. The
overall higher uptake of linkage to care in the meta-
analysis could be due to a number of factors. First, the
studies in the systematic review did not differentiate
newly diagnosed individuals from those who had previ-
ously obtained a positive HIV test result. It is plausible
that individuals who have received multiple positive test
results may be more likely to seek HIV care services
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Figure 2 Adjusted cumulative probability
of registration for HIV care after first
positive HIV diagnosis by testing
modality in Kisesa, Tanzania between
2014 and 2017, n = 411. VCT –
voluntary counselling and testing; facility-
based provider-initiated counselling and
testing had too few individuals for curve
to be drawn; allowed for 90 days of
follow-up, no event >71 days; adjusted
for sex, age, rurality of sub-village
(urban, peri-urban, rural), whether the
sub-village had access to a paved road,
and distance between household and
Kisesa health centre.
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than those diagnosed for the first time. Second, the
method of ascertainment of linkage to care included
participant self-reports, which may be affected by social
desirability bias [21]. Third, the meta-analysis included
studies that followed individuals up to 1 year to iden-
tify successful linkage compared to 90 days in our
study. However, very few individuals in our sample
linked to care between 91 and 365 days. Fourth, our
sample for facility-based PITC was restricted to ANC
users, whereas users of other facilities offering PITC,
such as outpatient clinics, may include sicker individu-
als. Finally, uptake of HIV care services in Kisesa has
consistently lagged behind other eastern and southern
African communities, likely due to community-level
stigma and other social and structural barriers [2, 8,
14, 22]. Notably, the systematic review found that
community-based HTC accompanied by facilitated link-
age to care by trained lay counsellors or health work-
ers achieved 95% linkage within 12 months [1].
Therefore, future sero-surveys should explore including
facilitated linkage to care among those diagnosed with
HIV as a way to improve linkage to care.
We found that individuals who resided in villages in
the eastern region of the study area (i.e. Ihayabuyaga and
Welamasonga) were less likely to link to care than those
in the other villages. In addition, linkage to care rates
were higher in Kitumba and Kanyama than in Kisesa vil-
lage in which the CTC is located. Given Kisesa village’s
proximity with the CTC, we hypothesise that individuals
who lived in the immediate area surrounding the clinics
may have been more likely to travel to obtain HIV care
outside of the surveillance area following a diagnosis
made within Kisesa, which would have resulted in the
attenuated effect. There is some evidence for this in a
previous study of ours that showed nearly half of all
clinic attendees in the CTC between 2015 and 2017 were
non-residents [17], which underscores the importance for
future trials and observational studies to include tracing
of diagnosed individuals to capture care received outside
the immediate area, where possible. Although the
proximity of each village to the CTC is likely to be a
key factor driving the differential linkage to care rates
by village, other factors through which village of
residence may be acting include access to CTC facilities
outside the study area and social factors like community-
level stigma.
Previous studies have highlighted the success of com-
munity-based HTC to identify asymptomatic HIV-posi-
tive individuals at relatively higher CD4 counts compared
with facility-based HTC [1, 9, 23]. Our findings are con-
sistent with these previous studies in that nearly half of
individuals diagnosed in the community-based sero-
survey had CD4 counts >500 cells/mm3 at care initiation
compared to only 16% of those diagnosed using facility-
based VCT. Of note, 74% of all newly diagnosed indi-
viduals in Kisesa who linked to care between 2014 and
2017 had CD4 < 500 cells/mm3 when they initiated care.
National treatment guidelines in Tanzania were to initi-
ate ART in individuals with CD4 < 500 cells/mm3 in
2015 [24], which expanded to all diagnosed individuals
in 2017 [25] to match current WHO guidelines [26].
Therefore, most individuals in our sample were eligible
for treatment when they linked to care, which corre-
sponds with the high level of ART initiation we observed
among those who did.
We conducted a sensitivity analysis on our regression
model to exclude individuals who were diagnosed and
linked to care in the same day. In this restricted model,
we still found a strong, albeit attenuated, association
between testing modality and linkage to care. We also
found the distance between an individual’s household
and the CTC played a role in the likelihood of success-
fully linking to care after restricting to those who would
have needed to travel back to the CTC on a subsequent
day to achieve linkage to care. These findings further
underscore the importance of providing equal access to
HIV care and treatment services irrespective of the dis-
tance from the nearest stationary CTC, including trans-
portation refunds. By the end of 2017, three village-based
health posts located within the Kisesa HDSS surveillance
area were offering ART directly to attendees in
addition to the CTC at Kisesa health centre. We are
currently assessing how best to link clinic records from
these less-frequented health posts into the linked data
infrastructure.
Our study had limitations. First, our analysis did not
capture linkage to care that occurred outside the study
area so the proportion who linked to care is likely to
be underestimated. If the decision to obtain care out-
side of Kisesa ward was related to modality of HIV
testing or any spatial characteristic (as may have been
the case for Kisesa village), the results in this paper
may be subjected to bias. We used all available data to
control for such bias, including limiting the analytic
sample to those who were resident in the study area as
of 2017. Second, we lacked sufficient power because of
the relatively small sample size, particularly among
those diagnosed using facility-based ANC-PITC, which
resulted in large standard errors of regression estimates.
A larger number of individuals who had already been
diagnosed with HIV in the facility-based sample may
have also allowed for a separate analysis among these
individuals to identify their likelihood of linkage to
care after multiple diagnoses.
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Conclusion
We measured linkage to care following a population-
level HIV serological surveillance round, which is a
form of community-based HTC not previously
included in systematic reviews on the topic. This anal-
ysis was made possible and strengthened by the novel
linked data infrastructure available in the Kisesa
observational HIV cohort study, which includes
directly observed data for HIV testing (both commu-
nity- and facility-based), diagnoses, care, and treat-
ment. We found that while overall linkage to care
was low among newly diagnosed adults in this rural
Tanzanian community, those diagnosed using facility-
based VCT had higher uptake of HIV care services
than those diagnosed using facility-based ANC-PITC
or in the community-based sero-survey. However, once
individuals were in care, there was no evidence of any
further delays to ART initiation by testing modality.
Community-based HTC is important for earlier diag-
nosis of HIV-positive individuals; however, these
efforts should include interventions to link individuals
newly diagnosed with HIV into care and provide sta-
tionary care and treatment services in all locations
offering HTC.
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